Review
Cell Death and Differentiation advance online publication 18 July 2008; doi: 10.1038/cdd.2008.113
Autophagy in CD4+ T-cell immunity and tolerance
Edited by G Kroemer
1Laboratory of Viral Immunobiology, Christopher H. Browne Center for Immunology and Immune Diseases, The Rockefeller University, Box 390, 1230 York Avenue, New York, NY 10021-6399, USA
Correspondence: C Münz, Laboratory of Viral Immunobiology, Christopher H. Browne Center for Immunology and Immune Diseases, The Rockefeller University, Box 390, 1230 York Avenue, New York, NY 10021-6399, USA. Tel: +1 212 327 7611; Fax: +1 212 327 7887; E-mail: munzc@rockefeller.edu
Received 3 June 2008; Revised 18 June 2008; Accepted 18 June 2008; Published online 18 July 2008.
Abstract
Autophagy is a homeostatic process that enables eukaryotic cells to deliver cytoplasmic constituents for lysosomal degradation, to recycle nutrients and to survive during starvation. In addition to these primordial functions, autophagy has emerged as a key mechanism in orchestrating innate and adaptive immune responses to intracellular pathogens. Autophagy restricts viral infections as well as replication of intracellular bacteria and parasites and delivers pathogenic determinants for TLR stimulation and for MHC class II presentation to the adaptive immune system. Apart from its role in defense against pathogens, autophagy-mediated presentation of self-antigens in the steady state could have a crucial role in the induction and maintenance of CD4+ T-cell tolerance. This review describes the mechanisms by which the immune system utilizes autophagic degradation of cytoplasmic material to regulate adaptive immune responses.
Keywords:
autophagy, immunity, MHC, T cell
Abbreviations:
CMA, chaperone-mediated autophagy; Atg, autophagy-related gene; TLR, Toll-like receptor; TNF, tumor necrosis factor; MHC, major histocompatibility complex; DRiPs, defective ribosomal products; TAP, transporter associated with antigen processing; Ii, invariant chain; CLIP, class II-associated Ii peptide; APC, antigen-presenting cell; MIIC, MHC class II containing compartment; HLA, human leukocyte antigen; DC, dendritic cell; EBV, Epstein–Barr virus; LAMP, lysosome-associated membrane protein
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Nature Medicine News and Views (01 May 2007)
Nature Medicine News and Views (01 May 2007)
RESEARCH
Journal of Investigative Dermatology Original Article
Engineering Oncolytic Measles Virus to Circumvent the Intracellular Innate Immune Response
Molecular Therapy Original Article

